Aakaar Medical Technologies Limited (NSE: AAKAAR) is a Mumbai, Maharashtra-based company in the Beauty Care Products industry. With a market capitalisation of ₹102 Cr, it ranks #3,227 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 12 in Beauty Care Products. At ₹72.00 (as of 19 Nov 2026), the share price is 3.4% below its 52-week high of ₹74.55 and 6.7% above its 52-week low of ₹67.45.
| Current Price | ₹72.00 |
|---|---|
| Market Cap | ₹102 Cr |
| NSE Symbol | AAKAAR |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Beauty Care Products |
| P/E Ratio | 14.4 |
| Return on Equity | 12.17% |
| Return on Assets | 9.54% |
| 52-Week Range | ₹67.45 – ₹74.55 |
| Beta (1Y) | 0.51 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.aakaarmedical.in |
Promoters held 67.05% of Aakaar Medical Technologies Limited's shares as of Sept 2026, against 67.01% in Sept 2025 (+0.04 percentage points).
Aakaar Medical Technologies Ltd. provides medical aesthetics and cosmetic dermatology treatment services. Its products include hair and skin care, injectables and contouring, and aesthetic devices. The company serves primarily to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists in Korea, Spain, Italy, and Austria. The company was incorporated in 2013 and is based in Mumbai, India.
1. Aesthetic Devices & Device Consumables-This segment offers aesthetic devices and consumables. 2. Aesthetic Products-This segment offers aesthetic devices and consumables. 3. Unallocated Employee Benefit Expense-NA 4. Unallocated Other Expense-NA
1. Aesthetic Devices & Device Consumables-11% 2. Aesthetic Products-89%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Godrej Consumer Products Ltd (GodrejCP) | ₹89,877 Cr | 48.1 | 15.10% | ₹4,413 Cr | -18.0% |
| Colgate-Palmolive (India) Ltd - Colpal | ₹47,162 Cr | 35.5 | 81.59% | ₹1,706 Cr | -18.3% |
| Gillette India Ltd. | ₹24,339 Cr | 37.3 | 66.44% | ₹846 Cr | -15.5% |
| Bajaj Consumer Care Ltd | ₹5,716 Cr | 30.9 | 25.31% | ₹333 Cr | +52.5% |
| Sacheerome Limited | ₹866 Cr | 28.8 | 19.16% | — | — |
| Radix Industries (India) Ltd | ₹210 Cr | 66.7 | 14.49% | — | -32.0% |
| Aakaar Medical Technologies Limited | ₹102 Cr | 14.4 | 12.17% | — | — |
| Ador Multiproducts Ltd. | ₹97 Cr | n/m | -4.04% | — | -16.0% |
| Ravelcare Limited | ₹67 Cr | 10.7 | — | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Aakaar Medical Technologies Limited is trading at ₹72.00, with a market capitalisation of ₹102 Cr.
Aakaar Medical Technologies Limited operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Beauty Care Products).
Aakaar Medical Technologies Limited has a P/E of 14.4 and a return on equity of 12.17%.
Aakaar Medical Technologies Limited is listed on the NSE under the symbol AAKAAR.
Promoters held 67.05% of Aakaar Medical Technologies Limited's shares as of Sept 2026, against 67.01% in Sept 2025 (+0.04 percentage points).
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.